Vimarsana
Biggest News Aggregation in the World

Page 2 - Evidence Taskforce News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Evidence Taskforce. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Evidence Taskforce Today - Breaking & Trending Today

I'm at home with COVID. When do I need to see a doctor? And what treatments are available? - Vimarsana News

I'm at home with COVID. When do I need to see a doctor? And what treatments are available?

Most people with COVID will recover at home without any treatment. But some people who are at risk of severe disease could benefit from new medicines to reduce the chance of the disease progressing.

Ivermectin proponents are using an editing error on A Current Affair to claim the Queen is being treated with the drug - 25-Feb-2022 - Vimarsana News

Ivermectin proponents are using an editing error on A Current Affair to claim the Queen is being treated with the drug - 25-Feb-2022

An editing blunder on Channel Nine's A Current Affair has this week led to a slew of misinformation, with some using it to claim the Queen is being treated for COVID-19 with ivermectin.

Do Not Treat COVID-19 With Malaria Tablets - Solomon Times Online - Vimarsana News

Do Not Treat COVID-19 With Malaria Tablets - Solomon Times Online

Those that test positive for COVID-19 or have symptoms of the virus must not take Malaria prescribed medication.

Unvaccinated Aussie MP took ivermectin horse drug to fight Covid - Vimarsana News

Unvaccinated Aussie MP took ivermectin horse drug to fight Covid

A Liberal MP revealed in parliament on Monday he is unvaccinated because it's 'safer than the vaccine' and used ivermectin to treat the virus after contracting it in January.

New Covid Oral Treatments Arriving in Australia - Vimarsana News

New Covid Oral Treatments Arriving in Australia

The AMA has been advised by the Department of Health that new oral treatments for COVID-19, Lagevrio® (molnupiravir) and Paxlovid® (nirmatrelvir